Alexander Hardy
Chief Executive Officer, BioMarin Pharmaceutical.
Companies
- BioMarin PharmaceuticalBoard member Dec 5, 2023 to now1
- BioMarin PharmaceuticalChief executive officer Dec 5, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioMarin Pharmaceutical BMRN214,635 shares2$11.8M at $54.75Mar 17, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 17, 2026Shares withheld for tax 4,252 shares at $56.05 of BioMarin Pharmaceutical2
- Mar 16, 2026Granted 62,440 shares of BioMarin Pharmaceutical3
- Mar 13, 2026Shares withheld for tax 2,941 shares at $58.51 of BioMarin Pharmaceutical3
- Dec 1, 2025Shares withheld for tax 16,570 shares at $55.03 of BioMarin Pharmaceutical4
- Apr 30, 2025Granted 375 shares at $54.14 of BioMarin Pharmaceutical4
- Mar 17, 2025Granted 44,360 shares of BioMarin Pharmaceutical5
- Mar 14, 2025Shares withheld for tax 2,933 shares at $69.44 of BioMarin Pharmaceutical5
- Nov 29, 2024Shares withheld for tax 14,295 shares at $66.03 of BioMarin Pharmaceutical6
- Oct 31, 2024Granted 300 shares at $56.01 of BioMarin Pharmaceutical6
- Mar 15, 2024Granted 32,780 shares of BioMarin Pharmaceutical7
- Dec 1, 2023Granted 47,332 shares of BioMarin Pharmaceutical8
- Dec 1, 2023Granted 68,039 shares of BioMarin Pharmaceutical8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 17, 2026
- 4SEC EDGARForm 4 filed Dec 2, 2025
- 5SEC EDGARForm 4 filed Mar 18, 2025
- 6SEC EDGARForm 4 filed Dec 3, 2024
- 7SEC EDGARForm 4 filed Mar 19, 2024
- 8SEC EDGARForm 4 filed Dec 5, 2023